Meeting
2021 ASCO Annual Meeting
Predictors of overall survival (OS) in patients (pts) with melanoma brain metastasis (MBM) in the modern era.
Authors
Merve Hasanov
The University of Texas MD Anderson Cancer Center, Houston, TX
Merve Hasanov , Denai R. Milton , Alicia Bea Davies , Elizabeth Sirmans , Chantal M Saberian , Eliza Posada , Jeffrey E. Gershenwald , Carlos A. Torres-Cabala , Jason T. Huse , Hussein Abdul-Hassan Tawbi , Isabella Claudia Glitza , Jing Li , Caroline Chung , Debra Yeboa , Sylvia Opusunju , Betty Y.S. Kim , Frederick F. Lang , Lauren Elaine Haydu , Michael A. Davies , Sherise D. Ferguson
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Advanced/Metastatic Disease
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 9540)
DOI
10.1200/JCO.2021.39.15_suppl.9540
Abstract #
9540
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Graded prognostic assessment index for melanoma with brain metastases (MBM).
First Author: Kwabena Osei-Boateng
Poster
2013 ASCO Annual Meeting
Vemurafenib (VEM) in patients (pts) with BRAF-mutant melanoma and brain metastases (mets).
First Author: James J. Harding
Poster
2023 ASCO Annual Meeting
Pretreatment clinical parameters associated with intracranial progression burden following an initial stereotactic radiosurgery course in a multi-institutional brain metastases cohort.
First Author: Christina C Huang
Poster
2023 ASCO Annual Meeting
Brain metastasis burden and management in small cell lung cancer: An analysis of 8705 patients.
First Author: Karolina Gaebe